We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
The White House has launched a national data dashboard of non-fatal opioid overdoses, which shows more than 180,000 people overdosed on opioids and survived in the past year, CNN reports.
Federal regulators are proposing an update to federal treatment regulations for opioid use disorder, STAT reports. The update would make permanent COVID-era policies that allow take-home doses of methadone and the use of telehealth to access buprenorphine prescriptions.
A new report by the U.S. Department of Health and Human Services’ Office of Inspector General criticizes the Food and Drug Administration’s lack of oversight of online tobacco retailers.
The company that makes the opioid overdose antidote Narcan announced this week that the U.S. Food and Drug Administration has fast-tracked its application for an over-the-counter version of the treatment, CBS News reports.
A new editorial on the pandemic and youth substance risk concludes COVID provided protective benefits for some, while contributing to risk factors for others.
View our curated digest of the latest research news, including an investigation of the indirect effects of theory of mind on binge drinking and alcohol use in underage drinkers.
Racial and ethnic disparities in treatment with the addiction medication buprenorphine increased between 2006 and 2020, according to a new study. Black and Hispanic patients received treatment for less time than white patients.
Walmart this week proposed paying $3.1 billion to settle lawsuits by state and local governments that alleged its pharmacies improperly filled prescriptions for opioids, the Associated Press reports.
View our curated digest of the latest research news, including a study examining the disruptions to U.S. local public health's role in population-based substance use prevention and response during COVID-19.
The Food and Drug Administration this week warned health professionals about xylazine, an animal medication that has been identified in human overdoses, CBS News reports.
View our curated digest of the latest research news, including the development of an electronic screening and brief Intervention to address perinatal substance use in home visiting.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
